Interventional Cardiology: Peripheral Vascular Disease Therapeutic Devices
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for therapeutic devices for the treatment of peripheral vasclar disease (PVD). Therapeutic devices covered by the scope of this report include:
- angioplasty catheters (POBA, DCB, cutting, and scoring balloon angioplasty catheters)
- vascular stents (bare-metal and drug-eluting stents)
- atherectomy catheters
- thromboembolectomy catheters
- chronic total occlusion crossing devices
The global market for PVD therapeutic devices is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2017-22). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually. Primary research querying interventional cardiologists regarding device preferences and utilization was leveraged in the formulation of this report's forecasts and analyses. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 7.2% during the 2017-22 forecast, increasing from approximately $4,151.3m in 2017 to an estimated $5,876.6m in 2022.